Skip to main content
Caplight Logo









Myconom Biomaterials

Myconom Biomaterials

Private
TurkeyEnergy & Sustainabilityhttps://myconom.com/

Last Round

Grant

Feb 26, 2024

Total Funding Raised

$153,600

Company Overview

Myconom Biomaterials is a biotechnology company that develops biodegradable composite materials using mushroom mycelium and agricultural waste as sustainable alternatives to plastic and petroleum-based products.

Sector

Energy & Sustainability

Verticals

Sustainable Materials, Advanced Materials, Circular Economy, Biotechnology, Green Building

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

mycelium materialsbiomaterialsmycelium packagingmushroom packagingacoustic panelssustainable materialscircular economyeco-designbiodegradable plasticgreen buildingbio-based compositesmyco-materialsupcycled materialscustom R&Dplastic-free packaging

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Myconom Biomaterials Comparables

Compare Myconom Biomaterials with similar companies based on industry and business-model similarity.

Myconom Biomaterials comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MycoLutions GmbH
90%
MycoFab
89%
Taftirium
86%

Myconom Biomaterials Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 26, 2024
GrantDec 8, 2022

Myconom Biomaterials Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2026

    Monthly visitors increased 256% MoM.

Myconom Biomaterials Filings

Explore SEC and related filing metadata, where available.

Myconom Biomaterials filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Myconom Biomaterials's valuation, stock price, and market status.

Is Myconom Biomaterials a public or private company?

Myconom Biomaterials is a private company.

What is the current stock price of Myconom Biomaterials?

Myconom Biomaterials is a private company with no public stock price. No recent secondary market data is available.

How much is Myconom Biomaterials worth (valuation)?

Valuation information for Myconom Biomaterials is not publicly available.

Can I buy Myconom Biomaterials stock?

Myconom Biomaterials shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Myconom Biomaterials's last funding round?

Myconom Biomaterials's most recent funding round was Grant on February 26, 2024.

Who are the main investors in Myconom Biomaterials?

Key investors in Myconom Biomaterials include Sabancı ARF.

Will Myconom Biomaterials IPO soon?

No public IPO plans have been announced for Myconom Biomaterials.

How can I track Myconom Biomaterials secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Myconom Biomaterials's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTurkey
Employee Range1
Year Founded2022
Last FundingFeb 26, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?